Hillsdale Investment Management’s Charles River Laboratories CRL Stock Holding History

Hillsdale Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,320	Closed	-$1.06M	–	680
2025 Q4	$1.06M	Sell	5,320 -1,000	-16%	-$181K	0.03%	354
2025 Q3	$989K	Buy	6,320 +6,200	+5,167%	+$985K	0.03%	356
2025 Q2	$18.2K	Buy	+120	New	+$16K	﹤0.01%	500
2021 Q1	–	Sell	-35	Closed	-$9K	–	563
2020 Q4	$9K	Buy	+35	New	+$8.34K	﹤0.01%	500
2017 Q1	–	Sell	-3,900	Closed	-$297K	–	482
2016 Q4	$297K	Hold	3,900	–	–	0.06%	235
2016 Q3	$325K	Sell	3,900 -500	-11%	-$41.9K	0.09%	243
2016 Q2	$363K	Hold	4,400	–	–	0.11%	201
2016 Q1	$334K	Buy	+4,400	New	+$326K	0.11%	248
2015 Q2	–	Sell	-7,100	Closed	-$563K	–	516
2015 Q1	$563K	Sell	7,100 -90	-1%	-$6.64K	0.14%	119
2014 Q4	$458K	Hold	7,190	–	–	0.12%	137
2014 Q3	$430K	Sell	7,190 -6,100	-46%	-$349K	0.14%	107
2014 Q2	$711K	Sell	13,290 -1,000	-7%	-$54.9K	0.16%	72
2014 Q1	$862K	Sell	14,290 -1,410	-9%	-$82.2K	0.24%	50
2013 Q4	$833K	Buy	15,700 +5,100	+48%	+$256K	0.24%	56
2013 Q3	$490K	Hold	10,600	–	–	0.15%	95
2013 Q2	$435K	Buy	+10,600	New	+$454K	0.14%	94

Other funds holding CRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hillsdale Investment Management's CRL Position: Q1 2026 in Review

Hillsdale Investment Management sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 5,320 shares — an estimated $1.06M sold.

Hillsdale Investment Management first reported a position in CRL in Q2 2013 and held it in 16 quarters. The position peaked at $1.06M in Q4 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Hillsdale Investment Management reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
Hillsdale Investment Management sold 5,320 Charles River Laboratories shares in Q1 2026, an estimated $1.06M.
Hillsdale Investment Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 16 quarters.
Hillsdale Investment Management's Charles River Laboratories position peaked at $1.06M in Q4 2025.
558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.